{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:28:31Z","timestamp":1794324511331,"version":"4.9.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ymgme.2021.06.009","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T20:22:52Z","timestamp":1624652572000},"page":"335-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Throwing a spotlight on under-recognized manifestations of Gaucher disease: Pulmonary involvement, lymphadenopathy and Gaucheroma"],"prefix":"10.1016","volume":"133","author":[{"given":"Uma","family":"Ramaswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelkrim","family":"Berrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeenaldeen","family":"AlSayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Broomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Donald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel M.","family":"seif El Dein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selena","family":"Freisens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Judith","family":"Peterschmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magy","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0005","first-page":"S16","article-title":"Lung involvement of Egyptian children with type 1 and 3 Gaucher disease: does enzyme replacement therapy have a role in reversing symptoms and can it be considered an index of disease severity?","volume":"111","author":"Abdelwahab","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2021.06.009_bb0010","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1097\/MPH.0000000000000297","article-title":"Mesenteric and mediastinal lymphadenopathy in Egyptian children with Gaucher disease types 1 and 3 treated with enzyme replacement therapy","volume":"37","author":"Abdelwahab","year":"2015","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0015","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.ymgme.2016.11.010","article-title":"Cardiac assessment in Egyptian type 3 Gaucher disease and report of calcifications in homozygous L444P mutation","volume":"120","author":"Abdelwahab","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2021.06.009_bb0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher\u2019s disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2021.06.009_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/02724936.1998.11747927","article-title":"Pulmonary involvement of Gaucher\u2019s disease in children: a common presentation in Saudi Arabia","volume":"18","author":"Banjar","year":"1998","journal-title":"Ann. Trop. Paediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2021.06.009_bb0030","first-page":"274","article-title":"Pharmacotherapy of Gaucher disease: current and future options","volume":"43","author":"Bennett","year":"2018","journal-title":"Pharmacy Ther."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0035","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.ymgme.2017.12.037","article-title":"Comorbidities in Gaucher disease","volume":"123","author":"Berrah","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0040","series-title":"Pulmonary Hypertension Case Report Herein","author":"Berrah","year":"2020"},{"issue":"1","key":"10.1016\/j.ymgme.2021.06.009_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pneumo.2011.07.002","article-title":"Syndrome h\u00e9patopulmonaire: une complication de la maladie de Gaucher de type 1 [Hepatopulmonary syndrome: a complication of type 1 Gaucher disease]","volume":"68","author":"Bouguila","year":"2012","journal-title":"Rev. Pneumol. Clin."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2014.08.011","article-title":"CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings","volume":"114","author":"Burrow","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2021.06.009_bb0055","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.chest.2015.09.011","article-title":"Lung transplantation in Gaucher Disease: a learning lesson in trying to avoid both scylla and charybdis","volume":"149","author":"de Boer","year":"2016","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2559.2012.04261.x","article-title":"Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme-substituted Gaucher disease","volume":"61","author":"den Bakker","year":"2012","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.ymgme.2021.06.009_bb0065","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2298\/VSP1112071D","article-title":"Pulmonary involvement in siblings with Gaucher disease type III","volume":"68","author":"Djordjevi\u0107","year":"2011","journal-title":"Vojnosanit. Pregl."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0070","first-page":"100490","article-title":"Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy","volume":"20","author":"El-Beshlawy","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"5","key":"10.1016\/j.ymgme.2021.06.009_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/15513810601123334","article-title":"Ultrastructural features of Gaucher disease treated with enzyme replacement therapy presenting as mesenteric mass lesions","volume":"25","author":"Fowler","year":"2006","journal-title":"Fetal Pediatr. Pathol."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0080","first-page":"177","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"69","author":"Gali\u00e8","year":"2016","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0085","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/ppul.24544","article-title":"Pulmonary manifestations in young Gaucher disease patients: phenotype-genotype correlation and radiological findings","volume":"55","author":"Gawad Tantawy","year":"2020","journal-title":"Pediatr. Pulmonol."},{"issue":"8","key":"10.1016\/j.ymgme.2021.06.009_bb0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/94.8.407","article-title":"Lung involvement and enzyme replacement therapy in Gaucher\u2019s disease","volume":"94","author":"Goitein","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.ymgme.2021.06.009_bb0095","first-page":"100893","article-title":"Lessons from lung transplantation: cause for redefining the pathophysiology of pulmonary hypertension in Gaucher disease","volume":"28","author":"Goobie","year":"2019","journal-title":"Respir. Med. Case Rep."},{"issue":"9","key":"10.1016\/j.ymgme.2021.06.009_bb0100","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.rmed.2012.06.014","article-title":"Different features of lung involvement in Niemann-Pick disease and Gaucher disease","volume":"106","author":"G\u00fclhan","year":"2012","journal-title":"Respir. Med."},{"issue":"12","key":"10.1016\/j.ymgme.2021.06.009_bb0105","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/BF03178036","article-title":"Radiographic findings in type 3b Gaucher disease","volume":"26","author":"Hill","year":"1996","journal-title":"Pediatr. Radiol."},{"issue":"1","key":"10.1016\/j.ymgme.2021.06.009_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13023-019-1244-9","article-title":"A comprehensive monocentric ophthalmic study with Gaucher disease type 3 patients: vitreoretinal lesions, retinal atrophy and characterization of abnormal saccades","volume":"14","author":"Hopf","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bcmd.2016.10.018","article-title":"Gaucheromas: when macrophages promote tumor formation and dissemination","volume":"68","author":"Ivanova","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2021.06.009_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024251","article-title":"Population-based cohort of 500 patients with Gaucher disease in Israel","volume":"9","author":"Jaffe","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.ymgme.2021.06.009_bb0125","first-page":"539","article-title":"Enfermedad de Gaucher. Estudio morfol\u00f3gico de ganglios linf\u00e1ticos al microscopio electr\u00f3nico [Gaucher\u2019s disease. Morphological study of lymph nodes by electron microscopy]","volume":"35","author":"Jim\u00e9nez Cardoso","year":"1978","journal-title":"Bol. Med. Hosp. Infant Mex."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1183\/09031936.96.09020340","article-title":"Pulmonary function abnormalities in type I Gaucher disease","volume":"9","author":"Kerem","year":"1996","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcmd.2016.09.002","article-title":"Appendiceal involvement in a patient with Gaucher disease","volume":"68","author":"Kocic","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0140","first-page":"101","article-title":"Rare case of hepatic Gaucheroma in a child on enzyme replacement therapy","volume":"32","author":"Korula","year":"2017","journal-title":"JIMD Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2021.06.009_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jimd.12131","article-title":"Treating lysosomal storage disorders: what have we learnt?","volume":"43","author":"Lachmann","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2021.06.009_bb0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ymgme.2011.12.010","article-title":"Progressive mesenteric lymphadenopathy with protein-losing enteropathy; a devastating complication in Gaucher disease","volume":"105","author":"Lee","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2021.06.009_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bcmd.2014.05.007","article-title":"Outcome of early-treated type III Gaucher disease patients","volume":"53","author":"Lee","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0160","first-page":"270","article-title":"An unusual presentation of Gaucher disease in an infant with progressive dyspnea","volume":"13","author":"Levy","year":"2013","journal-title":"Ochsner J."},{"issue":"3","key":"10.1016\/j.ymgme.2021.06.009_bb0165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10545-011-9313-9","article-title":"Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy","volume":"34","author":"Lo","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0170","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jimd.12188","article-title":"Reduction of large soft-tissue Gaucheromas with substrate reduction therapy","volume":"43","author":"Mahajan","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0175","series-title":"Lung Infiltration Case Report Herein","author":"Mengel","year":"2020"},{"key":"10.1016\/j.ymgme.2021.06.009_bb0180","series-title":"Lymphadenopathy Case Report Herein","author":"Mengel","year":"2020"},{"key":"10.1016\/j.ymgme.2021.06.009_bb0185","first-page":"13","article-title":"Successful therapy for protein-losing enteropathy caused by chronic neuronopathic Gaucher disease","volume":"6","author":"Mhanni","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"5","key":"10.1016\/j.ymgme.2021.06.009_bb0190","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1034\/j.1399-0004.2003.00060.x","article-title":"Pulmonary involvement in type 1 Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease","volume":"63","author":"Miller","year":"2003","journal-title":"Clin. Genet."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2021.06.009_bb0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1096-7192(02)00122-1","article-title":"Pulmonary hypertension in type 1 Gaucher\u2019s disease: genetic and epigenetic determinants of phenotype and response to therapy","volume":"77","author":"Mistry","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0200","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2009.07872.x","article-title":"Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis","volume":"147","author":"Mistry","year":"2009","journal-title":"Brit. J. Haematol."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2021.06.009_bb0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2016.11.006","article-title":"Gaucher disease: progress and ongoing challenges","volume":"120","author":"Mistry","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","article-title":"Gaucher disease epidemiology and natural history: a comprehensive review of the literature","volume":"22","author":"Nalysnyk","year":"2016","journal-title":"Hematology"},{"key":"10.1016\/j.ymgme.2021.06.009_bb0215","author":"National Gaucher Foundation"},{"issue":"1","key":"10.1016\/j.ymgme.2021.06.009_bb0220","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-8652(199705)55:1<28::AID-AJH5>3.0.CO;2-5","article-title":"Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 Gaucher patients","volume":"55","author":"Neudorfer","year":"1997","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0225","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood.V82.2.408.408","article-title":"Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months","volume":"82","author":"Pastores","year":"1993","journal-title":"Blood"},{"issue":"5\u20136","key":"10.1016\/j.ymgme.2021.06.009_bb0230","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/10428199809057621","article-title":"Non-Hodgkin\u2019s lymphoma associated with Gaucher\u2019s disease","volume":"31","author":"Perales","year":"1998","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.ymgme.2021.06.009_bb0235","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hep.23183","article-title":"Image of the month. Hepatic Gaucheroma mimicking focal nodular hyperplasia","volume":"50","author":"Poll","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0240","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1399-3046.2005.00251.x","article-title":"Bilateral lung transplant in Gauchers type-1 disease","volume":"9","author":"Rao","year":"2005","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bcmd.2016.06.009","article-title":"Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease","volume":"60","author":"Regenboog","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2021.06.009_bb0250","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/mt.2014.12","article-title":"A Hitchhiker\u2019s guide to the blood-brain barrier: in trans delivery of a therapeutic enzyme","volume":"22","author":"Sands","year":"2014","journal-title":"Mol. Ther."},{"issue":"3 Pt 1","key":"10.1016\/j.ymgme.2021.06.009_bb0255","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm.157.3.9706057","article-title":"Pulmonary manifestations of Gaucher disease: an increased risk for L444P homozygotes?","volume":"157","author":"Santamaria","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0260","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/jimd.12235","article-title":"The definition of neuronopathic Gaucher disease","volume":"43","author":"Schiffmann","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0265","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1097\/MPH.0000000000000763","article-title":"Massive mesenteric lymphadenpathy cuasung protein-losing enteropathy in Gaucher dsease","volume":"29","author":"Simpson","year":"2017","journal-title":"Pediatric Hematol\/Oncol."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0270","first-page":"S135","article-title":"Gaucheroma mimicking hepatocellular carcinoma in a cirrhotic type I Gaucher disease patient","volume":"123","author":"Starosta","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0275","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1750-1172-7-77","article-title":"The French Gaucher\u2019s disease registry: clinical characteristics, complications and treatment of 562 patients","volume":"7","author":"Stirnemann","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0280","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0285","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1183\/09031936.94.07020409","article-title":"Value of bronchoalveolar lavage in lipidoses with pulmonary involvement","volume":"7","author":"Tabak","year":"1994","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0290","first-page":"114","article-title":"Macitentan in the treatment of pulmonary hypertension in Gaucher\u2019s disease","volume":"23","author":"Taylan","year":"2020","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0295","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcmd.2016.11.006","article-title":"Histological characterisation of visceral changes in a patient with type 2 Gaucher disease treated with enzyme replacement therapy","volume":"68","author":"Tezuka","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0300","series-title":"Poster presentation at the 13th Asia-Pacific Conference on Human Genetics","article-title":"Preliminary result of Eliglustat combination therapy for ERT resistant soft tissue involvement in Pediatric Gaucher disease","author":"Tsai","year":"2019"},{"key":"10.1016\/j.ymgme.2021.06.009_bb0305","first-page":"100473","article-title":"Very rare condition of multiple Gaucheroma: A case report and review of the literature","volume":"20","author":"Tseng","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2021.06.009_bb0310","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.1007\/s10545-010-9176-5","article-title":"Pulmonary hemorrhage in type 3 Gaucher disease: A case report","volume":"33","author":"Vellodi","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2021.06.009_bb0315","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/pbc.21948","article-title":"Giant lymphadenopathy infiltrated by gaucher cells mimicking lymphoma","volume":"52","author":"Ya\u011fci","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"issue":"5","key":"10.1016\/j.ymgme.2021.06.009_bb0320","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0899-7071(98)00028-X","article-title":"High-resolution CT pulmonary findings in adults with Gaucher\u2019s disease","volume":"22","author":"Yassa","year":"1998","journal-title":"Clin. Imaging"},{"issue":"20","key":"10.1016\/j.ymgme.2021.06.009_bb0325","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4103\/0366-6999.191825","article-title":"Gaucher disease with mesenteric lymphadenopathy: a case with 13-year follow-up","volume":"129","author":"Ye","year":"2016","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ymgme.2021.06.009_bb0330","series-title":"Gaucheroma Case Report Herein","author":"Yoo","year":"2020"},{"issue":"2","key":"10.1016\/j.ymgme.2021.06.009_bb0335","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.24957","article-title":"Demographics and patient characteristics of 1209 patients with Gaucher disease: descriptive analysis from the Gaucher Outcome Survey (GOS)","volume":"93","author":"Zimran","year":"2018","journal-title":"Am. J. Hematol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:50:33Z","timestamp":1761090633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1096719221007381"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.06.009","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Throwing a spotlight on under-recognized manifestations of Gaucher disease: Pulmonary involvement, lymphadenopathy and Gaucheroma","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}